Penny Stocks Alert:OncoSec Medical Inc (ONCS), Nuvilex, Inc. (OTCQB:NVLX … – Techsonian (press release)

Las Vegas, NV – May 17, 2014 — (TechSonian) – OncoSec Medical Inc (OTCMKTS:ONCS) a company developing its ImmunoPulse DNA-based immunotherapy to treat solid tumors, will present at seven events in May. The company’s itinerary includes a number of prominent scientific and investment conferences, culminating in a presentation at the 2014 ASCO Annual Meeting.

OncoSec Medical Inc(OTCMKTS:ONCS) opened the session at $0.76, trading in a range of $ $ 0.79, and closed at $0.784. The stock showed a positive performance of +4.26% in the last trading session. The stock traded on a volume of 1.13million shares and the average volume of the stock remained 2.33million shares.

Why Should Investors Buy ONCS After The Recent Gain? Just Go Here and Find Out

Nuvilex, Inc. (OTCQB:NVLX) reported last week that it signed an agreement with the University of Northern Colorado to perform initial studies in the development of cancer treatments that combine the proprietary live-cell encapsulation technology Cell-in-a-Box® with constituents of cannabis known as cannabinoids.

NuvilexInc(OTCMKTS:NVLX) traded 1.02million shares in the last business day while the average volume of the stock remained 5.35million shares. The stock showed a negative movement of -0.79% to end at $0.314. The 52 week range of the stock remained $ 0.02 – $ 0.62.

Has NVLXFound The Bottom And Ready To Gain Momentum? Find Out Here

GreenGro Technologies, Inc. (OTCMKTS:GRNH) reported the official grand opening of its Anaheim California store on May 15th. The Vertical Hydrogarden store soft opened this month with some 30,000 product offerings on shelves around the store.

GreenGro Technologies, Inc.(OTCMKTS:GRNH) reported 879,503.00 shares were exchanged during the last trade, while the average volume is about 2.09million shares. The stock dropped -5.89% and finished the day at $0.240. The beta of the stock is recorded at 5.06.

Why Should Investors Buy GRNHAfter the Recent Fall? Just Go Here and Find Out

Roche Holding Ltd. (ADR)(OTCMKTS:RHHBY) reported that its member Genentech announced that new data on nine approved and 18 investigational medicines will be presented during the 50th American Society of Clinical Oncology (ASCO) Annual Meeting.

Roche Holding Ltd. (ADR)(OTCMKTS:RHHBY) the stockincreased+0.86% and finished the session at $37.72.Traded with volume of 834,127.00 shares in the prior session and the average volume of the stock remained 815,870.00 shares.

For How Long RHHBYwill Fight for Profitability? Read This Trend Analysis report

This entry passed through the Full-Text RSS service — if this is your content and you’re reading it on someone else’s site, please read the FAQ at fivefilters.org/content-only/faq.php#publishers.